Tranexamic acid-d2-1

Modify Date: 2024-01-02 18:21:59

Tranexamic acid-d2-1 structure	Common Name	Tranexamic acid-d2-1
	CAS Number	2714435-89-7	Molecular Weight	159.22
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₈H₁₃D₂NO₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Tranexamic acid-d2-1

Tranexamic acid-d2-1 is the deuterium labeled Tranexamic acid[1]. Tranexamic acid (Transamin) is an antifibrinolytic for blocking lysine-binding sites of plasmin and elastase-derived plasminogen fragments with IC50 of 5 mM[2][3].

Name	Tranexamic acid-d2-1

Description	Tranexamic acid-d2-1 is the deuterium labeled Tranexamic acid[1]. Tranexamic acid (Transamin) is an antifibrinolytic for blocking lysine-binding sites of plasmin and elastase-derived plasminogen fragments with IC50 of 5 mM[2][3].
Related Catalog	Signaling Pathways >> Others >> Others
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. Bhat A, et al. Tranexamic acid overdosage-induced generalized seizure in renal failure. Saudi J Kidney Dis Transpl. 2014 Jan-Feb;25(1):130-2. [3]. Couturier R, et al. Continuous or discontinuous tranexamic acid effectively inhibits fibrinolysis in children undergoing cardiac surgery with cardiopulmonary bypass. Blood Coagul Fibrinolysis. 2014 Jan 13.

Molecular Formula	C₈H₁₃D₂NO₂
Molecular Weight	159.22

Tranexamic acid-d2-1

Use of Tranexamic acid-d2-1

Names

Tranexamic acid-d2-1 Biological Activity

Chemical & Physical Properties